Nikolai I. Tankovich
President at Stemedica Cell Technologies, Inc.
Profile
Nikolai I.
Tankovich is currently the Director at Biopharma Scientific, Inc. and the President, Director & Chief Medical Officer at Stemedica Cell Technologies, Inc. He holds a doctorate degree from Moscow State University Lomonosov and Semashco Medical University, and a graduate degree from Moscow University.
Nikolai I. Tankovich active positions
Companies | Position | Start |
---|---|---|
Biopharma Scientific, Inc.
Biopharma Scientific, Inc. Pharmaceuticals: MajorHealth Technology Biopharma Scientific, Inc. develops and manufactures pharmaceuticals. It provides new frontier of nutrition through nanotechnology delivery systems, innovations in bio-active extraction processes and advanced formulation methodologies. The company was founded by John H. Maher and Bruce L. Howe in 2004 and is headquartered in San Diego, CA | Director/Board Member | - |
Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Stemedica Cell Technologies, Inc. operates as a biotechnology company that manufactures adult allergenic stem cells. Its adult stem cells which are used by research institutions and hospitals for pre-clinical and clinical studies. It has offices in Mexico, Italy, Switzerland, and France. The company was founded by Roger J. Howe and Maynard A. Howe in 2005 and is headquartered in San Diego, CA. | President | - |
Training of Nikolai I. Tankovich
Semashco Medical University | Doctorate Degree |
Moscow University | Graduate Degree |
Moscow State University Lomonosov | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Biopharma Scientific, Inc.
Biopharma Scientific, Inc. Pharmaceuticals: MajorHealth Technology Biopharma Scientific, Inc. develops and manufactures pharmaceuticals. It provides new frontier of nutrition through nanotechnology delivery systems, innovations in bio-active extraction processes and advanced formulation methodologies. The company was founded by John H. Maher and Bruce L. Howe in 2004 and is headquartered in San Diego, CA | Health Technology |
Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Stemedica Cell Technologies, Inc. operates as a biotechnology company that manufactures adult allergenic stem cells. Its adult stem cells which are used by research institutions and hospitals for pre-clinical and clinical studies. It has offices in Mexico, Italy, Switzerland, and France. The company was founded by Roger J. Howe and Maynard A. Howe in 2005 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Nikolai I. Tankovich